TrialNeurology(R) neuroimmunology & neuroinflammation2020

Effect of the sphingosine-1-phosphate receptor modulator ozanimod on leukocyte subtypes in relapsing MS.

Sarah Harris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.